Fuller & Thaler Asset Management Inc. Raises Stake in Henry Schein, Inc. $HSIC

Key Points

• Fuller & Thaler Asset Management Inc. increased its holdings in Henry Schein, Inc. by 9.7% after acquiring an additional 4,679 shares, bringing their total to 52,868 shares valued at approximately $3.62 million.
• Brokerages have recently adjusted their ratings on Henry Schein, with Baird R W downgrading the stock from "strong-buy" to "hold" and setting new target prices around $75.
• Henry Schein’s recent quarterly earnings reported $1.10 EPS, missing analyst estimates, while revenue increased 3.3% year-over-year, totaling $3.24 billion.

Fuller & Thaler Asset Management Inc. increased its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 9.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 52,868 shares of the company's stock after purchasing an additional 4,679 shares during the quarter. Fuller & Thaler Asset Management Inc.'s holdings in Henry Schein were worth $3,621,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in HSIC. Investment Management Corp VA ADV acquired a new position in Henry Schein during the fourth quarter worth about $32,000. Rakuten Securities Inc. acquired a new position in Henry Schein during the first quarter worth about $34,000. Whittier Trust Co. raised its stake in Henry Schein by 714.3% during the first quarter. Whittier Trust Co. now owns 798 shares of the company's stock worth $55,000 after acquiring an additional 700 shares in the last quarter. UMB Bank n.a. increased its stake in shares of Henry Schein by 23.2% in the first quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock valued at $73,000 after buying an additional 201 shares during the period. Finally, Allworth Financial LP increased its stake in shares of Henry Schein by 24.5% in the first quarter. Allworth Financial LP now owns 1,178 shares of the company's stock valued at $78,000 after buying an additional 232 shares during the period. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Trading Down 1.4%

Shares of HSIC stock traded down $0.9520 during trading hours on Monday, hitting $68.6480. 666,022 shares of the company were exchanged, compared to its average volume of 1,759,880. The firm has a market cap of $8.32 billion, a P/E ratio of 22.11, a P/E/G ratio of 2.30 and a beta of 0.81. Henry Schein, Inc. has a fifty-two week low of $60.56 and a fifty-two week high of $82.49. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41. The company has a 50 day simple moving average of $70.55 and a two-hundred day simple moving average of $70.30.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The firm had revenue of $3.24 billion during the quarter, compared to analyst estimates of $3.22 billion. During the same quarter in the prior year, the business earned $1.23 earnings per share. The business's quarterly revenue was up 3.3% on a year-over-year basis. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Equities analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current year.

Analyst Upgrades and Downgrades

HSIC has been the subject of several recent research reports. Baird R W downgraded Henry Schein from a "strong-buy" rating to a "hold" rating in a research note on Monday, July 14th. Stifel Nicolaus reaffirmed a "hold" rating and issued a $75.00 price objective (down previously from $80.00) on shares of Henry Schein in a research note on Friday, July 25th. Leerink Partners set a $75.00 target price on Henry Schein in a research report on Monday, July 14th. Wells Fargo & Company lowered their target price on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. Finally, Barrington Research lowered their target price on Henry Schein from $86.00 to $78.00 and set an "outperform" rating for the company in a research report on Wednesday, August 6th. Four equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $75.58.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.